Healthcare is one of the world's largest and most critical industries, yet also one of the most outdated. Inefficiency, administrative burden, slow innovation cycles, and skyrocketing costs have created a massive opportunity for technology-driven transformation.
Attack Capital provides accredited investors with direct access to YC-backed HealthTech startups, early-stage medical technology companies, and category-defining founders building the future of digital health. We make it simple to invest in digital health companies and invest in HealthTech startups through a single, curated portfolio.
Investing in healthtech isn't just financially rewarding; it directly improves lives. Investors gain exposure to innovations that strengthen clinical outcomes, expand care access, and modernize healthcare delivery.
Key Advantages of Early-Stage HealthTech Investing
Attack Capital is a YC-backed venture builder, VC fund, and AI venture partner operating as a modern venture studio. We use a repeatable studio model of venture that lets investors invest in X companies across HealthTech and AI with a single, diversified allocation, while we identify and support the strongest HealthTech companies.
Attack Capital get early access to emerging Y Combinator-backed companies, including the most promising HealthTech startups.
Invest in HealthTech companiesInstead of choosing a single startup, investors gain exposure to 15–20 YC digital health companies, including:
Attack Capital evaluates companies using a rigorous process across:
Attack Capital invests alongside top healthcare and technology investors, including Global Founders Capital, Slow Ventures & YC Continuity. You gain access to healthcare technology venture capital quality normally reserved for institutional funds.
Invest in HealthTech companiesWe connect investors to elite digital health and medical technology opportunities.
If you're wondering how to invest in HealthTech companies without screening hundreds of deals yourself, Attack Capital simplifies it through a single, diversified HealthTech allocation. Our YC Demo Day Access Fund provides a streamlined way to invest in healthtech companies without needing to source, evaluate, or negotiate your own deals.
Submit your accredited investor verification to gain access to private HealthTech investments and YC HealthTech deal flow.
Receive Attack Capital HealthTech investment thesis, detailed deal memo, and curated list of the top digital health companies in the YC batch.
Start with a $10,000 minimum and gain exposure to a diversified portfolio of high-growth healthcare technology startups, turning a single allocation into multiple healthcare technology investments.
Receive quarterly updates on valuations, clinical progress, regulatory milestones, and follow-on rounds.
Healthcare provider organizations form the backbone of the global health system. This category includes hospitals, nursing homes, physician groups, rehabilitation centers, health insurers, and even veterinary care operators. These organizations represent large-scale, high-retention markets for HealthTech and digital transformation tools. For investors, this shift unlocks major opportunities across:
Attack Capital evaluates provider-focused startups based on regulatory readiness, clinical workflow integration, and their ability to deliver measurable improvements in outcomes and financial performance. Investing in pharmaceutical-aligned HealthTech unlocks exposure to:
The pharmaceutical industry remains one of the most innovation-driven sectors in global healthcare. Demand for new treatments continues to grow due to chronic disease prevalence, aging populations, and unmet medical needs. Startups in this space range from emerging biotech ventures to digital drug development platforms leveraging AI and multimodal models. Key categories include:
Attack Capital prioritizes companies with strong scientific foundations, validated clinical potential, and scalable platforms capable of transforming drug development timelines. Investors gain access to early-stage technologies that can meaningfully accelerate treatment breakthroughs.
The MedTech category includes devices, diagnostics, equipment, robotics, monitoring tools, and consumables used across every layer of care delivery. The industry surpassed US$500B in 2022 and is projected to reach US$800B by 2030, driven by aging populations, AI integration, and demand for minimally invasive care.
Attack Capital invests in medical technology companies that combine clinical utility, regulatory readiness, and scalable engineering. Best-in-class devices deliver measurable clinical impact while meeting FDA/CE standards and demonstrating strong provider adoption
Invest in HealthTech companies at the earliest stage, before Series A, capturing maximum upside from high-growth digital health startups and emerging medical technology innovators.
Attack Capital team evaluates FDA pathways, HIPAA compliance, clinical workflows, and regulatory strategy to ensure you invest in healthcare startups with strong foundations and long-term defensibility.
Gain rare early access to YC HealthTech companies backed by leading healthcare VCs, giving you priority allocation into top digital health and medical technology investment opportunities.
Invest across telehealth, diagnostics, automation, genomics, and medical technology through a curated, diversified Attack Capital HealthTech portfolio designed to reduce risk and maximize long-term sector exposure.
As a YC-backed venture builder and company builder, Attack Capital identifies HealthTech founders with clinical credibility, technical excellence, and early product-market fit, increasing investment success rates.
Attack Capital studio model of venture supports HealthTech startups with GTM strategy, compliance planning, and early scaling, improving performance and increasing the likelihood of strong investor returns.
Don't miss your chance to invest in healthtech companies shaping the future of digital health. Join Attack Capital and invest in the next generation of healthcare industry leaders.
Become a HealthTech Investor